103_CD Alliance_NNP UniChem_NNP Plc_NNP 42_CD ACQUISITIONS_NNP CONTINUED_VBD Purchase_NN of_IN businesses_NNS continued_VBD Retail_NNP Book_NNP Provisional_NNP value_NN at_IN Fair_NNP value_NN fair_JJ value_NN at_IN acquisition_NN adjustments_NNS acquisition_NN Assets_NNS acquired_VBN at_IN book_NN and_CC provisional_JJ fair_JJ value_NN million_CD million_CD million_CD Intangible_JJ assets_NNS retail_JJ pharmacy_NN licences_VBZ 24.7_CD 69.2_CD 93.9_CD Property_NN ,_, plant_NN and_CC equipment_NN 6.7_CD 0.2_CD 6.5_CD Inventories_NNS 11.2_CD 0.5_CD 10.7_CD Trade_NNP and_CC other_JJ receivables_NN 9.2_CD 0.2_CD 9.4_CD Borrowings_NNS bank_NN overdrafts_NNS 2.5_CD 2.5_CD bank_NN loans_NNS 2.5_CD 2.5_CD Trade_NNP and_CC other_JJ payables_NNS 10.7_CD 10.7_CD Current_JJ corporate_JJ tax_NN liabilities_NNS 3.3_CD 0.1_CD 3.4_CD Deferred_JJ tax_NN liabilities_NNS 20.6_CD 20.6_CD Net_JJ assets_NNS acquired_VBN 32.8_CD 48.0_CD 80.8_CD Consideration_NNP paid_VBD million_CD Cash_NNP 117.3_CD Deferred_JJ consideration_NN movement_NN 0.3_CD 117.0_CD Purchased_VBN goodwill_NN 36.2_CD Retail_NNP acquisitions_NNS comprised_VBD the_DT acquisition_NN of_IN 83_CD pharmacies_NNS in_IN the_DT UK_NNP ,_, Norway_NNP and_CC The_DT Netherlands_NNP ._.
43_CD DISPOSALS_NNP Disposal_NNP of_IN businesses_NNS During_IN the_DT year_NN the_DT Group_NNP disposed_VBD of_IN 51_CD %_NN of_IN its_PRP$ interest_NN in_IN Alliance_NNP UniChem_NNP Farmacutica_NNP A._NN G._NNP its_PRP$ entire_JJ interest_NN in_IN Elvetec_NNP in_IN France_NNP and_CC a_DT number_NN of_IN other_JJ minor_JJ interests_NNS ._.
The_DT proceeds_NNS received_VBD for_IN these_DT transactions_NNS were_VBD 32.5_CD million_CD ._.
Within_IN the_DT balance_NN sheets_NNS of_IN the_DT businesses_NNS disposed_VBN were_VBD net_JJ overdrafts_NNS of_IN 66.2_CD million_CD ._.
In_IN addition_NN ,_, the_DT Group_NNP received_VBD deferred_VBN consideration_NN of_IN 12.0_CD million_CD arising_VBG from_IN the_DT disposal_NN of_IN non-core_JJ UK_NNP businesses_NNS in_IN 2004_CD ._.
Disposal_NN of_IN investments_NNS in_IN associates_NNS As_IN described_VBN in_IN note_NN 42_CD ,_, during_IN the_DT year_NN the_DT Group_NNP restructured_VBD its_PRP$ relationship_NN with_IN Galenica_NNP A._NNP G._NNP ._.
The_DT transaction_NN was_VBD settled_VBN on_IN a_DT net_JJ basis_NN and_CC resulted_VBD in_IN a_DT net_JJ cash_NN inflow_NN to_TO the_DT Group_NNP of_IN 15.7_CD million_CD ._.
This_DT comprised_VBN 8.6_CD million_CD of_IN net_JJ proceeds_NNS ,_, 41.4_CD million_CD of_IN associate_JJ loans_NNS being_VBG repaid_VBN and_CC ,_, in_IN respect_NN of_IN the_DT acquired_VBN companies_NNS ,_, 2.0_CD million_CD of_IN net_JJ cash_NN and_CC 36.3_CD million_CD of_IN borrowings_NNS were_VBD held_VBN in_IN the_DT acquired_VBN balance_NN sheets_NNS ._.
In_IN addition_NN ,_, the_DT Group_NNP disposed_VBD of_IN a_DT minor_JJ associated_VBN undertaking_NN for_IN disposal_NN proceeds_NNS of_IN 0.1_CD million_CD ._.
Disposal_NN of_IN available-for-sale_JJ investments_NNS During_IN the_DT first_JJ half_NN of_IN the_DT year_NN ,_, the_DT Group_NNP disposed_VBD of_IN its_PRP$ investment_NN in_IN Sanacorp_NNP Pharmahandel_NNP A._NN G._NNP ._.
44_CD SHARE-BASED_JJ PAYMENTS_NNS The_DT Group_NNP issues_NNS equity_NN settled_VBD ,_, share-based_JJ payments_NNS to_TO certain_JJ employees_NNS ._.
Equity_NNP settled_VBD share-based_JJ payments_NNS are_VBP measured_VBN at_IN fair_JJ value_NN at_IN the_DT date_NN of_IN grant_NN ._.
The_DT fair_JJ value_NN determined_VBN at_IN the_DT grant_NN date_NN of_IN the_DT equity_NN settled_VBD ,_, share-based_JJ payments_NNS is_VBZ expensed_VBN on_IN a_DT straight-line_JJ basis_NN over_IN the_DT vesting_JJ period_NN ,_, based_VBN on_IN the_DT Groups_NNS estimate_NN of_IN shares_NNS that_WDT will_MD eventually_RB vest_NN ._.
Fair_NNP value_NN is_VBZ measured_VBN by_IN use_NN of_IN an_DT actuarial_JJ binomial_JJ model_NN ._.
The_DT model_NN includes_VBZ adjustments_NNS ,_, based_VBN on_IN managements_NNS best_JJS estimate_NN ,_, for_IN the_DT effects_NNS of_IN exercise_NN restrictions_NNS ,_, behavioural_JJ considerations_NNS and_CC expected_VBN dividend_NN payments_NNS ._.
The_DT option_NN life_NN is_VBZ derived_VBN by_IN the_DT model_NN based_VBN on_IN these_DT assumptions_NNS and_CC the_DT other_JJ assumptions_NNS identified_VBN below_IN ._.
The_DT total_JJ expense_NN included_VBD within_IN profit_NN from_IN operations_NNS in_IN respect_NN of_IN share-based_JJ payments_NNS was_VBD 5.3_CD million_CD 2004_CD 2.2_CD million_CD ._.
104_CD Alliance_NNP UniChem_NNP Plc_NNP Notes_NNP to_TO the_DT financial_JJ statements_NNS for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2005_CD 44_CD SHARE-BASED_JJ PAYMENTS_NNS CONTINUED_VBD Further_JJ details_NNS of_IN the_DT different_JJ types_NNS of_IN share-based_JJ payments_NNS are_VBP as_IN follows_VBZ :_: Discretionary_JJ 1997_CD Share_NN Option_NN Scheme_NNP The_NNP Group_NNP operates_VBZ a_DT discretionary_JJ share_NN option_NN scheme_NN for_IN certain_JJ employees_NNS whereby_WRB options_NNS become_VBP exercisable_JJ on_IN the_DT achievement_NN of_IN certain_JJ financial_JJ earnings_NNS per_IN share_NN performance_NN targets_NNS by_IN the_DT Group_NNP ._.
Options_NNS granted_VBN under_IN the_DT scheme_NN since_IN May_NNP 2003_CD have_VBP no_DT retesting_NN of_IN performance_NN measures_NNS and_CC have_VBP a_DT fixed_JJ performance_NN period_NN being_VBG a_DT defined_VBN three_CD year_NN period_NN made_VBD up_IN of_IN three_CD consecutive_JJ accounting_NN periods_NNS ._.
This_DT period_NN commences_NNS on_IN 1_CD January_NNP of_IN the_DT year_NN of_IN the_DT award_NN ._.
The_DT option_NN price_NN is_VBZ set_VBN at_IN the_DT market_NN price_NN of_IN the_DT Companys_NNP shares_NNS ._.
For_IN those_DT share_NN option_NN awards_NNS which_WDT gave_VBD rise_NN to_TO an_DT expense_NN in_IN the_DT year_NN ,_, the_DT assumptions_NNS used_VBN in_IN the_DT calculation_NN of_IN the_DT fair_JJ values_NNS were_VBD as_IN follows_VBZ :_: Grant_NNP date_NN 21_CD May_NNP 2003_CD 19_CD March_NNP 2004_CD 6_CD May_NNP 2005_CD 19_CD May_NNP 2005_CD 26_CD October_NNP 2005_CD Exercise_NN price_NN 489.0_CD p_VBP 556.0_CD p_JJ 810.5_CD p_NN 818.2_CD p_VBP 759.2_CD p_JJ Vesting_JJ period_NN years_NNS 34_CD 34_CD 3_CD 4_CD 3_CD Contractual_JJ lifetime_NN years_NNS 7_CD 7_CD 7_CD 7_CD 7_CD Expected_VBN volatility_NN 28_CD %_NN 28_CD %_NN 26_CD %_NN 26_CD %_NN 26_CD %_NN Expected_VBN option_NN life_NN years_NNS 3.94.6_CD 3.94.6_CD 4.2_CD 4.8_CD 4.2_CD Risk_NNP free_JJ rate_NN 3.9_CD %_NN 4.5_CD %_NN 4.6_CD %_NN 4.6_CD %_NN 4.3_CD %_NN 4.6_CD %_NN Expected_VBN dividends_NNS expressed_VBD as_IN a_DT dividend_NN yield_NN 3.1_CD %_NN 3.1_CD %_NN 2.3_CD %_NN 2.3_CD %_NN 2.3_CD %_NN Fair_NN value_NN pence_NN 117.1_CD p121_CD .3_CD p_NN 136.5_CD p142_CD .5_CD p_NN 206.4_CD p_VBP 214.6_CD p_JJ 193.3_CD p_NN The_DT expected_VBN volatility_NN is_VBZ based_VBN on_IN the_DT historic_JJ volatility_NN of_IN the_DT Companys_NNP share_NN price_NN over_IN the_DT expected_VBN life_NN of_IN the_DT option_NN ._.
The_DT movement_NN during_IN the_DT year_NN of_IN the_DT total_JJ outstanding_JJ options_NNS in_IN respect_NN of_IN the_DT awards_NNS identified_VBN above_IN is_VBZ provided_VBN below_RB ._.
The_DT analysis_NN of_IN the_DT outstanding_JJ options_NNS by_IN award_NN date_NN at_IN the_DT beginning_NN and_CC the_DT end_NN of_IN the_DT year_NN is_VBZ provided_VBN in_IN note_NN 34_CD ._.
Weighted_JJ average_JJ Number_NN exercise_NN price_NN Outstanding_JJ at_IN 1_CD January_NNP 2005_CD 3,803,295_CD 522.4_CD p_NN Granted_VBN 1,753,506_CD 810.3_CD p_NN Lapsed_VBN 128,971_CD 647.5_CD p_NN Exercised_VBN 159,000_CD 520.2_CD p_NN Outstanding_JJ at_IN 31_CD December_NNP 2005_CD 5,268,830_CD 615.2_CD p_NN None_NN of_IN the_DT share_NN options_NNS identified_VBN above_IN as_IN outstanding_JJ at_IN 31_CD December_NNP 2005_CD had_VBD vested_VBN at_IN that_DT date_NN ._.
Savings_NNS Related_VBN Scheme_NNP The_NNP Group_NNP provides_VBZ UK_NNP employees_NNS with_IN the_DT ability_NN to_TO participate_VB in_IN the_DT Groups_NNS Save_NNP As_IN You_PRP Earn_VBP SAYE_NNP scheme_NN which_WDT allows_VBZ qualifying_VBG employees_NNS the_DT opportunity_NN to_TO make_VB regular_JJ savings_NNS over_IN a_DT fixed_JJ period_NN of_IN three_CD ,_, five_CD or_CC seven_CD years_NNS ._.
These_DT savings_NNS accumulate_VBP with_IN interest_NN at_IN a_DT guaranteed_VBN rate_NN ._.
At_IN the_DT end_NN of_IN the_DT savings_NNS contracts_NNS a_DT bonus_NN is_VBZ added_VBN to_TO the_DT savings_NNS and_CC participants_NNS have_VBP the_DT option_NN to_TO use_VB their_PRP$ savings_NNS to_TO buy_VB shares_NNS in_IN Alliance_NNP UniChem_NNP Plc_NNP at_IN a_DT fixed_VBN price_NN ._.
In_IN common_JJ with_IN other_JJ UK_NNP companies_NNS ,_, the_DT option_NN price_NN is_VBZ set_VBN at_IN a_DT 20_CD %_NN discount_NN to_TO the_DT market_NN price_NN of_IN the_DT Companys_NNP shares_NNS at_IN the_DT date_NN of_IN grant_NN ._.
Exercise_NN of_IN an_DT option_NN is_VBZ subject_JJ to_TO continued_JJ employment_NN ._.
For_IN those_DT share_NN options_NNS issued_VBN under_IN SAYE_NNP schemes_NNS which_WDT gave_VBD rise_NN to_TO an_DT expense_NN in_IN the_DT year_NN ,_, the_DT assumptions_NNS used_VBN in_IN the_DT calculation_NN of_IN the_DT fair_JJ values_NNS were_VBD as_IN follows_VBZ :_: Grant_NNP date_NN 17_CD April_NNP 2003_CD 6_CD April_NNP 2004_CD 5_CD April_NNP 2005_CD Exercise_NN price_NN 337.0_CD p_NN 440.0_CD p_VBP 589.5_CD p_JJ Vesting_JJ period_NN years_NNS 3_CD ,_, 5_CD or_CC 7_CD 3_CD ,_, 5_CD or_CC 7_CD 3_CD ,_, 5_CD or_CC 7_CD Expected_VBN volatility_NN 28_CD %_NN 28_CD %_NN 26_CD %_NN Expected_VBN option_NN life_NN years_NNS 3.77.7_CD 3.77.7_CD 3.67.5_CD Risk_NNP free_JJ rate_NN 3.9_CD %_NN 4.4_CD %_NN 4.7_CD %_NN 4.9_CD %_NN 4.7_CD %_NN Expected_VBN dividends_NNS expressed_VBD as_IN a_DT dividend_NN yield_NN 3.3_CD %_NN 2.9_CD %_NN 2.4_CD %_NN Fair_NN value_NN 141.9_CD p156_CD .6_CD p_NN 202.5_CD p225_NNS .8_CD p_NN 267.1_CD p304_CD .4_CD p_NN The_DT expected_VBN volatility_NN is_VBZ based_VBN on_IN the_DT historic_JJ volatility_NN of_IN the_DT Companys_NNP share_NN price_NN over_IN the_DT expected_VBN life_NN of_IN the_DT option_NN ._.
105_CD Alliance_NNP UniChem_NNP Plc_NNP 44_CD SHARE-BASED_NNP PAYMENTS_NNS CONTINUED_VBD Savings_NNP Related_NNP Scheme_NNP continued_VBD The_DT movement_NN during_IN the_DT year_NN of_IN the_DT total_JJ outstanding_JJ options_NNS in_IN respect_NN of_IN the_DT schemes_NNS identified_VBN above_IN is_VBZ provided_VBN below_RB ._.
Weighted_JJ average_JJ Number_NN exercise_NN price_NN Outstanding_JJ at_IN 1_CD January_NNP 2005_CD 2,072,606_CD 376.4_CD p_NN Granted_VBN 691,918_CD 589.5_CD p_NN Lapsed_VBN 2,251_CD 387.7_CD p_NN Forfeited_NNP 124,283_CD 437.9_CD p_NN Cancelled_NNP 113,041_CD 429.3_CD p_NN Exercised_VBN 11,565_CD 364.0_CD p_NN Outstanding_JJ at_IN 31_CD December_NNP 2005_CD 2,513,384_CD 429.7_CD p_NN None_NN of_IN the_DT share_NN options_NNS identified_VBN above_IN as_IN outstanding_JJ at_IN 31_CD December_NNP 2005_CD had_VBD vested_VBN at_IN that_DT date_NN ._.
Long-term_JJ incentive_NN plan_NN The_DT long-term_JJ incentive_NN plan_NN is_VBZ a_DT discretionary_JJ arrangement_NN under_IN which_WDT allocations_NNS are_VBP made_VBN to_TO executive_JJ Directors_NNS with_IN the_DT aim_NN of_IN rewarding_VBG them_PRP for_IN creating_VBG shareholder_NN value_NN ._.
Each_DT allocation_NN takes_VBZ the_DT form_NN of_IN a_DT non-binding_JJ statement_NN of_IN intent_NN to_TO make_VB an_DT award_NN of_IN a_DT stated_VBN maximum_NN amount_NN following_VBG the_DT end_NN of_IN a_DT specified_VBN performance_NN period_NN ._.
The_DT allocation_NN is_VBZ determined_VBN as_IN a_DT percentage_NN of_IN basic_JJ salary_NN in_IN the_DT year_NN that_IN the_DT performance_NN period_NN starts_VBZ ._.
The_DT amount_NN of_IN the_DT award_NN is_VBZ dependent_JJ on_IN the_DT achievement_NN of_IN certain_JJ performance_NN measures_NNS during_IN the_DT performance_NN period_NN that_IN the_DT remuneration_NN committee_NN believe_VBP are_VBP the_DT most_RBS appropriate_JJ measure_NN of_IN the_DT underlying_VBG performance_NN of_IN the_DT Group_NNP ._.
The_DT award_NN takes_VBZ the_DT form_NN of_IN a_DT right_NN to_TO acquire_VB ordinary_JJ shares_NNS in_IN the_DT Company_NN for_IN a_DT nominal_JJ sum_NN within_IN a_DT period_NN of_IN ten_CD years_NNS from_IN the_DT date_NN of_IN the_DT award_NN ._.
The_DT number_NN of_IN shares_NNS will_MD be_VB determined_VBN by_IN the_DT market_NN price_NN of_IN the_DT Companys_NNP shares_NNS at_IN the_DT date_NN of_IN the_DT award_NN ._.
Further_JJ details_NNS are_VBP provided_VBN in_IN the_DT Board_NNP report_NN on_IN remuneration_NN ._.
For_IN those_DT awards_NNS which_WDT gave_VBD rise_NN to_TO an_DT expense_NN in_IN the_DT year_NN ,_, the_DT assumptions_NNS used_VBN in_IN the_DT calculation_NN of_IN the_DT fair_JJ values_NNS were_VBD as_IN follows_VBZ :_: 2003 2004 2005_CD allocation_NN allocation_NN allocation_NN Grant_NNP date_NN 7_CD March_NNP 19_CD February_NNP 18_CD February_NNP 2003 2004 2005_CD Exercise_NN price_NN 0.001_CD p_VBP 0.001_CD p_JJ 0.001_CD p_NN Vesting_JJ period_NN years_NNS 333_CD Possibility_NN of_IN ceasing_VBG employment_NN before_IN vesting_VBG 0_CD %_NN 0_CD %_NN 0_CD %_NN Expectation_NN of_IN meeting_NN performance_NN criteria_NNS 70.3_CD %_NN 70.3_CD %_NN 71.7_CD %_NN The_DT movement_NN during_IN the_DT year_NN of_IN the_DT total_JJ outstanding_JJ allocations_NNS in_IN respect_NN of_IN the_DT awards_NNS identified_VBN above_IN is_VBZ provided_VBN below_RB ._.
The_DT analysis_NN of_IN the_DT outstanding_JJ allocations_NNS by_IN award_NN date_NN at_IN the_DT end_NN of_IN the_DT year_NN and_CC the_DT comparative_JJ year_NN is_VBZ provided_VBN in_IN the_DT Board_NNP report_NN on_IN remuneration_NN ._.
Allocation_NNP Outstanding_JJ at_IN 1_CD January_NNP 2005_CD 2,493,331_CD Granted_VBN 2,425,000_CD Forfeited_NNP 521,666_CD Outstanding_JJ at_IN 31_CD December_NNP 2005_CD 4,396,665_CD None_NN of_IN the_DT allocations_NNS identified_VBN above_IN as_IN outstanding_JJ at_IN 31_CD December_NNP 2005_CD had_VBD vested_VBN at_IN that_DT date_NN ._.
